Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 19.814.86-11.939.9461.19

What is the latest Core EBITDA Growth ratio of EMCURE PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of EMCURE PHARMACEUTICALS is 19.81 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202519.81
Mar20244.86
Mar2023-11.93
Mar20229.94
Mar202161.19

How is Core EBITDA Growth of EMCURE PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 19.81
307.61
Mar2024 4.86
Positive
Mar2023 -11.93
Negative
Mar2022 9.94
-83.76
Mar2021 61.19 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹37,102.5 Cr 1.5% 4.4% 33.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,312.0 Cr 3.1% 7.2% 18.3% Stock Analytics
DIVIS LABORATORIES ₹213,879.0 Cr 8.2% 19.8% 17.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹194,094.0 Cr -1.8% 4.9% 37.2% Stock Analytics
CIPLA ₹118,992.0 Cr 3.9% 0.6% 0% Stock Analytics
DR REDDYS LABORATORIES ₹95,787.4 Cr -0.7% -14.6% -8.4% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

1.5%

4.4%

33.6%

SENSEX

2.7%

1.5%

-5.6%


You may also like the below Video Courses